Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Toxic hepatitis due to a food supplement: "Natural" is no synonym for "harmless".

Couturier FJ, Colemont LJ, Fierens H, Verhoeven VM.

Clin Res Hepatol Gastroenterol. 2016 Mar 9. pii: S2210-7401(16)00030-9. doi: 10.1016/j.clinre.2015.12.016. [Epub ahead of print]

PMID:
26971288
2.

Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).

Piroth L, Moinot L, Yeni P, Avettand-Fénoel V, Reynes J, Girard PM, Marchou B, Georget A, Rouzioux C, Autran B, Duvillard L, Chêne G, Fagard C; ANRS 141 TIPI Trial Study Group.

J Antimicrob Chemother. 2016 Feb;71(2):490-6. doi: 10.1093/jac/dkv369. Epub 2015 Nov 14.

PMID:
26568566
3.

The Besrour Conferences: Collaborating to strengthen global family medicine.

Rouleau K, Ponka D, Arya N, Couturier F, Siedlecki B, Redwood-Campbell L, Lemire F.

Can Fam Physician. 2015 Jul;61(7):578-81, 587-91. English, French. No abstract available.

4.

Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort.

Protopopescu C, Raffi F, Spire B, Hardel L, Michelet C, Cheneau C, Le Moing V, Leport C, Carrieri MP; ANRS CO8 APROCO-COPILOTE Study Group.

Antivir Ther. 2015;20(7):763-72. doi: 10.3851/IMP2960. Epub 2015 Apr 10.

PMID:
25859625
5.

Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.

Bastard JP, Fellahi S, Couffignal C, Raffi F, Gras G, Hardel L, Sobel A, Leport C, Fardet L, Capeau J; ANRS CO8 APROCO-COPILOTE Cohort Study Group.

J Antimicrob Chemother. 2015;70(6):1816-24. doi: 10.1093/jac/dkv036. Epub 2015 Mar 1.

6.

[Erratum to "Medication adverse events: Impact of pharmaceutical consultations during the hospitalization of patients" [Ann. Pharm. Fr. 72 (2014) 440-450].]

Santucci R, Levêque D, Herbrecht R, Fischbach M, Gérout AC, Untereiner C, Bouayad-Agha K, Couturier F.

Ann Pharm Fr. 2015 Jan 8. pii: S0003-4509(14)00137-0. doi: 10.1016/j.pharma.2014.12.002. [Epub ahead of print] French. No abstract available.

PMID:
25578947
7.

[Medication adverse events: Impact of pharmaceutical consultations during the hospitalization of patients].

Santucci R, Levêque D, Herbrecht R, Fischbach M, Gérout AC, Untereiner C, Bouayad-Agha K, Couturier F.

Ann Pharm Fr. 2014 Nov;72(6):440-50. doi: 10.1016/j.pharma.2014.05.003. Epub 2014 Jul 8. French. Erratum in: Ann Pharm Fr. 2015 Mar;73(2):160-1.

PMID:
25438655
8.

Quality of care, risk management, and technology in obstetrics to reduce hospital-based maternal mortality in Senegal and Mali (QUARITE): a cluster-randomised trial.

Dumont A, Fournier P, Abrahamowicz M, Traoré M, Haddad S, Fraser WD; QUARITE research group.

Lancet. 2013 Jul 13;382(9887):146-57. doi: 10.1016/S0140-6736(13)60593-0. Epub 2013 May 28.

PMID:
23721752
9.

Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.

Protopopescu C, Raffi F, Brunet-François C, Salmon D, Verdon R, Reboud P, Carrieri MP, Leport C, Spire B, Michel L; APROCO-COPILOTE (ANRS CO8) Study Group.

Antivir Ther. 2012;17(6):1079-83. doi: 10.3851/IMP2102. Epub 2012 Apr 27.

PMID:
22544079
10.

[Ciprofloxacin-induced thrombopenia].

Santucci R, Bouayad-Agha K, Maloisel F, Couturier F.

Med Mal Infect. 2012 Apr;42(4):175-6. doi: 10.1016/j.medmal.2012.02.008. Epub 2012 Apr 3. French. No abstract available.

PMID:
22475418
11.

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.

Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Ceron D, Protopopescu C, Leport C, Raffi F, Chêne G; ANRS CO8 APROCO-COPILOTE Cohort Study Group.

AIDS. 2012 Jan 28;26(3):303-14. doi: 10.1097/QAD.0b013e32834e8776.

PMID:
22089377
12.

Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability.

Préau M, Protopopescu C, Raffi F, Rey D, Chêne G, Marcellin F, Perronne C, Ragnaud JM, Leport C, Spire B; Anrs Co8 Aproco-Copilote Study Group.

AIDS Care. 2012;24(4):434-43. doi: 10.1080/09540121.2011.613909. Epub 2011 Oct 14.

PMID:
21999644
13.

Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy.

Masquelier B, Taieb A, Reigadas S, Marchou B, Cheneau C, Spire B, Charpentier C, Leport C, Raffi F, Chêne G, Descamps D; APROCO-COPILOTE study group.

J Antimicrob Chemother. 2011 Jul;66(7):1582-9. doi: 10.1093/jac/dkr153. Epub 2011 Apr 27.

14.

What should Tropical Doctor publish - and what should it not?

Doherty T, Couturier F, Donnelly J, Lavy C.

Trop Doct. 2010 Oct;40(4):193. doi: 10.1258/td.2010.10e001. No abstract available.

PMID:
20870676
15.

Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?

Laurichesse JJ, Taieb A, Capoulade-Metay C, Katlama C, Villes V, Drobacheff-Thiebaud MC, Raffi F, Chêne G, Theodorou I, Leport C; ANRS C08 Aproco-Copilote Study Group.

HIV Med. 2010 Apr;11(4):239-44. doi: 10.1111/j.1468-1293.2009.00769.x. Epub 2009 Dec 28.

16.

Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.

Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, Bohlius J, Schmidlin K, Costagliola D, Fätkenheuer G, May M, Caro-Murillo AM, Mocroft A, Bonnet F, Clifford G, Karafoulidou A, Miro JM, Lundgren J, Chene G, Egger M.

Antivir Ther. 2009;14(8):1065-74. doi: 10.3851/IMP1462.

17.

[Maternal mortality audits in low-resource countries: analysis of 23 hospitals in Senegal and Mali (the QUARITE study)].

Dortonne JR, Dumont A, Traore M, Perreault G, Couturier F, Kanouté K.

J Obstet Gynaecol Can. 2009 Oct;31(10):936-44. French.

PMID:
19941723
18.

QUARITE (quality of care, risk management and technology in obstetrics): a cluster-randomized trial of a multifaceted intervention to improve emergency obstetric care in Senegal and Mali.

Dumont A, Fournier P, Fraser W, Haddad S, Traore M, Diop I, Gueye M, Gaye A, Couturier F, Pasquier JC, Beaudoin F, Lalonde A, Hatem M, Abrahamowicz M.

Trials. 2009 Sep 18;10:85. doi: 10.1186/1745-6215-10-85.

19.

Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.

Protopopescu C, Raffi F, Roux P, Reynes J, Dellamonica P, Spire B, Leport C, Carrieri MP; ANRS CO8 APROCO-COPILOTE Study Group.

J Antimicrob Chemother. 2009 Sep;64(3):599-606. doi: 10.1093/jac/dkp232. Epub 2009 Jul 14.

20.

Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort study.

Ferry T, Raffi F, Collin-Filleul F, Dupon M, Dellamonica P, Waldner A, Strady C, Chêne G, Leport C, Moing VL; ANRS CO8 (APROCO-COPILOTE) Study Group.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):407-15. doi: 10.1097/QAI.0b013e3181acb65f.

PMID:
19474755
Items per page

Supplemental Content

Loading ...
Write to the Help Desk